# Cannabinoids and Cerebellar-Motor Functioning

> **NCT01853020** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 57 (actual)

## Conditions studied

- Cannabis
- Psychotic Disorders

## Interventions

- **DRUG:** THC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01853020
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-04-07
- **Final completion:** 2015-04-07
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01853020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01853020, "Cannabinoids and Cerebellar-Motor Functioning". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01853020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*